First Trust Nasdaq Pharmaceuticals ETF Rating $27.99 +0.12 (+0.42%) As of 02/21/2025 03:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy 2.62Holdings in FTXH have an aggregate rating of Moderate Buy based on 759 analyst ratings issued in the past year covering 50 companies (100.0% of the portfolio).FTXH Aggregate Price Target$27.99High Prediction$27.99Average Prediction$27.99Low Prediction$27.99Holdings in FTXH have an aggregate price target of $27.99 and a range of $27.99 to $27.99 covering 50 companies (100.0% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy28 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 FTXH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.75%BMYBristol-Myers Squibb$55.85+0.1%4.5959 of 5 stars2.30$57.86 3.6%20Analyst RevisionPositive News7.64%ABBVAbbVie$202.03+0.6%4.6572 of 5 stars2.88$208.35 3.1%24Dividend AnnouncementAnalyst RevisionPositive News7.36%JNJJohnson & Johnson$162.35+1.7%4.4114 of 5 stars2.56$170.67 5.1%18Ex-DividendAnalyst ForecastOptions VolumePositive News6.88%PFEPfizer$26.32+1.6%4.9993 of 5 stars2.50$31.92 21.3%16Options VolumePositive News5.71%MRKMerck & Co., Inc.$89.40+2.0%5 of 5 stars2.58$116.39 30.2%24Analyst DowngradeOptions Volume4.76%GILDGilead Sciences$109.95-0.1%4.7947 of 5 stars2.72$102.08 -7.2%29Analyst UpgradeInsider TradeOptions VolumeAnalyst RevisionPositive News4.45%CAHCardinal Health$126.96-0.3%4.6999 of 5 stars2.75$136.87 7.8%16Analyst RevisionPositive News3.72%JAZZJazz Pharmaceuticals$136.01-0.5%4.9068 of 5 stars2.93$180.33 32.6%15Upcoming EarningsNews CoveragePositive News3.71%ZTSZoetis$160.39+1.9%4.8787 of 5 stars3.08$214.90 34.0%123.67%UTHRUnited Therapeutics$361.10-1.7%4.3818 of 5 stars2.67$388.25 7.5%12Insider TradePositive News3.52%LLYEli Lilly and Company$874.12+0.1%4.8538 of 5 stars2.85$1,007.94 15.3%20Positive News3.47%AMGNAmgen$303.01+1.7%4.4751 of 5 stars2.46$314.09 3.7%24Insider TradePositive News3.43%VTRSViatris$11.25+1.7%2.3267 of 5 stars2.00$13.67 21.5%3News Coverage2.66%BIIBBiogen$140.64+2.6%4.7515 of 5 stars2.43$211.85 50.6%30Analyst Forecast2.44%OGNOrganon & Co.$15.47-1.4%4.9279 of 5 stars2.43$20.80 34.5%72.19%REGNRegeneron Pharmaceuticals$700.33+0.6%4.6674 of 5 stars2.76$973.13 39.0%25Dividend Announcement2.00%CRLCharles River Laboratories International$163.11+0.5%4.7976 of 5 stars1.88$195.71 20.0%16Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage1.80%MEDPMedpace$340.78-1.2%4.275 of 5 stars2.45$381.44 11.9%111.53%ELANElanco Animal Health$11.02-1.0%4.0519 of 5 stars2.25$16.00 45.2%8Analyst Forecast1.36%NBIXNeurocrine Biosciences$120.69+3.9%4.9825 of 5 stars2.83$166.90 38.3%23Analyst DowngradeBuyback AnnouncementAnalyst RevisionGap Up1.30%HALOHalozyme Therapeutics$57.75+0.5%4.4627 of 5 stars2.60$62.78 8.7%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.23%ALKSAlkermes$35.33-0.5%3.6896 of 5 stars2.82$38.36 8.6%111.08%EXELExelixis$36.85+5.0%4.5093 of 5 stars2.55$37.24 1.0%20Analyst UpgradeInsider Trade1.05%CORTCorcept Therapeutics$63.54-2.4%4.6892 of 5 stars3.00$88.25 38.9%5Upcoming Earnings1.04%PBHPrestige Consumer Healthcare$84.66-0.1%3.9802 of 5 stars2.60$92.60 9.4%5Positive News0.94%ITCIIntra-Cellular Therapies$128.60+0.0%3.8947 of 5 stars2.53$103.62 -19.4%15Earnings ReportAnalyst ForecastNews Coverage0.90%PRGOPerrigo$25.37+0.5%4.9671 of 5 stars2.40$35.00 38.0%5Dividend IncreaseAnalyst DowngradeNews Coverage0.72%TGTXTG Therapeutics$30.88-0.2%4.483 of 5 stars2.83$40.67 31.7%6Positive News0.69%ALNYAlnylam Pharmaceuticals$250.59-0.2%4.4628 of 5 stars2.72$299.48 19.5%25Analyst ForecastInsider Trade0.65%PTGXProtagonist Therapeutics$38.75+0.7%3.8064 of 5 stars3.00$56.00 44.5%9Earnings ReportAnalyst ForecastInsider TradeNews CoverageGap Up0.60%VCELVericel$52.00-4.3%2.9448 of 5 stars3.00$63.14 21.4%7Positive News0.60%ACADACADIA Pharmaceuticals$19.95-1.7%2.5793 of 5 stars2.53$24.00 20.3%17Upcoming EarningsShort Interest ↓0.58%TWSTTwist Bioscience$41.31-8.4%4.6084 of 5 stars2.70$53.80 30.2%100.58%BPMCBlueprint Medicines$92.25-2.2%2.9944 of 5 stars2.65$123.83 34.2%20Earnings ReportAnalyst Upgrade0.57%INSMInsmed$81.06-3.0%4.0523 of 5 stars3.00$91.00 12.3%15Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage0.55%INCYIncyte$72.05+0.9%4.541 of 5 stars2.35$75.59 4.9%200.50%ADMAADMA Biologics$15.84-1.5%3.544 of 5 stars3.25$21.25 34.2%40.50%ACLXArcellx$63.75-2.8%2.0095 of 5 stars3.13$105.93 66.2%15Upcoming Earnings0.50%AMRXAmneal Pharmaceuticals$7.83-0.5%3.7675 of 5 stars2.80$10.00 27.7%5Positive News0.50%VRTXVertex Pharmaceuticals$484.24+0.8%4.1169 of 5 stars2.65$505.61 4.4%26Analyst DowngradeInsider TradeAnalyst RevisionPositive News0.46%ROIVRoivant Sciences$10.68-0.4%2.5595 of 5 stars3.00$18.08 69.3%7Insider Trade0.45%EXASExact Sciences$49.26-0.5%4.6972 of 5 stars2.95$72.06 46.3%19Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.44%SRPTSarepta Therapeutics$106.28-2.0%4.5118 of 5 stars2.87$176.77 66.3%23Upcoming Earnings0.42%KRYSKrystal Biotech$187.86+2.9%4.4803 of 5 stars3.00$210.00 11.8%8Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.42%BMRNBioMarin Pharmaceutical$68.25-0.7%4.9188 of 5 stars2.70$93.81 37.4%23Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.42%RNAAvidity Biosciences$31.12-4.3%1.6172 of 5 stars3.00$65.80 111.4%100.39%KYMRKymera Therapeutics$36.81-1.6%2.3443 of 5 stars2.88$55.06 49.6%17News CoverageGap Up0.36%IONSIonis Pharmaceuticals$32.33-1.1%4.4271 of 5 stars2.70$60.00 85.6%20Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.25%VKTXViking Therapeutics$34.07+7.7%4.3881 of 5 stars3.00$97.29 185.5%15High Trading Volume0.24%MYGNMyriad Genetics$14.19-5.3%3.8395 of 5 stars2.07$22.54 58.8%14Analyst Downgrade This page (NASDAQ:FTXH) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FTXH Stock Alerts